Glossary · Conditions

Vaginal dryness (vulvovaginal atrophy)

Also called: Vulvovaginal atrophy, Atrophic vaginitis.

Definition: Vaginal dryness is one of the most common menopausal symptoms, caused by estrogen withdrawal that thins the vaginal epithelium and reduces secretions. It manifests as dryness, burning, itching, and painful sex. The older medical term was vulvovaginal atrophy or atrophic vaginitis; modern terminology folds it into genitourinary syndrome of menopause.

Detailed definition

Vaginal dryness in menopause is the result of estrogen-receptor-rich vaginal epithelium and submucosal glands losing their estrogen signal. The epithelium thins, glycogen content drops, lactobacilli decrease, vaginal pH rises from premenopausal acidic (3.5–4.5) to alkaline (5.5–7.0), and natural lubrication declines sharply. Symptoms include daily dryness, burning, itching, post-coital irritation, dyspareunia, and reduced sexual response. Onset is gradual; many women don't notice severity until they realize sex has become uncomfortable or they have recurrent UTIs. First-line conservative measures are over-the-counter vaginal moisturizers (used several times weekly) and lubricants (used at intercourse). Definitive treatment is local estrogen — cream, tablet, vaginal ring, or insert — which restores epithelial thickness, glycogen, lactobacilli, and pH within 6–12 weeks. Intravaginal DHEA (prasterone) and oral ospemifene are non-estrogen options.

Why it matters in menopause

Many women normalize vaginal dryness as "just part of aging." It is treatable, the treatment is low-risk, and resolution generally improves overall quality of life and sexual function. ClearedRx prescribes vaginal estrogen as a stand-alone or alongside systemic HRT, with cream and tablet being the most common starting points.

Sources

External references: Wikipedia.

← Back to full glossary